English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 17, 2026

IDEAYA and Servier report positive trial results for metastatic eye cancer drug
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

Replimune faces layoffs and site closures after FDA rejects melanoma drug again
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

USP adds Tamiflu and Trulicity to list of drugs vulnerable to supply disruptions
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Podcast discusses the future of funding in European biotech sector
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

AGC Biologics outlines benefits of modular bioreactors for flexible drug manufacturing
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

FDA’s transparency policy on rejection letters changes biopharma communication practices
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Revolution Medicines reports pancreatic cancer drug doubles survival in late-stage trial
+ Pharmaceuticals
Patient Daily | Apr 16, 2026

Allogene reports early success for cell therapy in lymphoma trial interim analysis

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes